Vardenafil Hydrochloride Tablet, Film Coated
Product Images NDC 0093-7652

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 0093-7652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of vardenafil hydrochloride dihydrate, showing the molecular arrangement including heterocyclic rings, functional groups, and hydration.*

FDA Label Image

Image 10

Vardenafil Hydrochloride Tablets 2.5 mg film-coated oral tablets label. The package contains 30 tablets and is labeled by Teva Pharmaceuticals USA, Inc. The label includes dosage instructions, storage conditions, manufacturer information, and a barcode.*

FDA Label Image

Image 11

Vardenafil Hydrochloride Tablets 5 mg film-coated oral tablets label by Teva Pharmaceuticals USA, Inc. The label indicates the package contains 30 tablets and includes dosing instructions stating each tablet contains 5 mg of vardenafil HCl. Storage conditions and manufacturing information are also shown, including the NDC 0093-7653-56 and a caution to dispense with the patient information leaflet.*

FDA Label Image

Image 12

Label for Vardenafil Hydrochloride Tablets 10 mg oral film-coated tablets by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 30 tablets and includes dosage instructions, storage conditions, manufacturer information, and a barcode.*

FDA Label Image

Image 13

Label for Vardenafil Hydrochloride Tablets 20 mg, film-coated oral tablets by Teva Pharmaceuticals USA, Inc. The label includes dispensing instructions, storage conditions, and a package count of 30 tablets. The label displays the NDC 0093-7655-56 and emphasizes pharmacist instructions to dispense with patient information leaflet.*

FDA Label Image

Image 2

A set of three line graphs showing mean maximal changes over time in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) during vardenafil treatment before NTG. Timing points include 24 hours, 8 hours, 4 hours, and 1 hour, with error bars indicating variability.*

FDA Label Image

Image 3

A line graph depicting the mean change in mmHg over a 6-hour time period for placebo and Vardenafil 5 mg under simultaneous and 8-hour separation conditions. The y-axis represents mean change in mmHg, and the x-axis represents time in hours. Four data sets are shown with distinct markers illustrating blood pressure changes over time.*

FDA Label Image

Image 4

A line graph depicting mean change in mmHg over time (hours) for placebo and Vardenafil 5 mg under simultaneous and 8-hour separation dosing conditions. The graph compares blood pressure changes for these four groups across a 6-hour period.*

FDA Label Image

Image 5

A line graph depicting mean change in mmHg over time in hours. It compares Placebo treated groups (Stage 1 and Stage 2) with Vardenafil 10 mg and 20 mg dosages, showing trends of blood pressure changes across a 6-hour period.*

FDA Label Image

Image 6

A line graph depicting mean change in mmHg over time in hours for Vardenafil 5 mg and 10 mg doses compared to placebo (Stage 1 and Stage 2). The x-axis represents time in hours (0 to 6), and the y-axis shows mean change in mmHg (-10 to 10). Different symbols denote each group, illustrating blood pressure changes.*

FDA Label Image

Image 7

A line graph titled 'TERAZOSIN' depicting mean change in mmHg (y-axis) over time in hours (x-axis) for various dosing conditions of vardenafil. Different markers and lines represent placebo, 10 mg, and 20 mg vardenafil, each under 6-hour separation and simultaneous conditions, showing blood pressure changes over a 6-hour period.*

FDA Label Image

Image 8

A line graph titled 'TAMSULOSIN' showing mean change in mmHg over time (0 to 6 hours) for different groups: placebo, 10 mg vardenafil, and 20 mg vardenafil, with data for 6-hour separation and simultaneous administration. The graph compares blood pressure changes across these variables.*

FDA Label Image

Image 9

Pharmacokinetic plasma concentration-time curve displaying Vardenafil Hydrochloride levels (µg/L) over 24 hours (h). The graph shows plasma concentration peaking shortly after dosing, followed by a gradual decline over time with error bars indicating variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.